Global IVD Infectious Diseases Market Research Report 2025(Status and Outlook)

March 2025 | 219 pages | ID: G0F7862AAC43EN
Bosson Research

Abstracts

Report Overview

In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to help detect infection, Diagnose a medical condition and Prevent disease.

This report provides a deep insight into the global IVD Infectious Diseases market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global IVD Infectious Diseases Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the IVD Infectious Diseases market in any manner.

Global IVD Infectious Diseases Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

BD

BioMerieux

Abbott

Quidel

Gen-Probe

Abbott

Danaher

Sysmex

Orasure

Hologic

Cepheid

Qiagen

Roche Diagnostics

Siemens Healthcare

Bio-Rad Laboratories

Market Segmentation (by Type)

Immunochemistry

Molecular Diagnostics

Market Segmentation (by Application)

Clinical Laboratories

Diagnostic Centers

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the IVD Infectious Diseases Market
• Overview of the regional outlook of the IVD Infectious Diseases Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the IVD Infectious Diseases Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of IVD Infectious Diseases
1.2 Key Market Segments
1.2.1 IVD Infectious Diseases Segment by Type
1.2.2 IVD Infectious Diseases Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global IVD Infectious Diseases Market Overview
2.1 Global Market Overview
2.1.1 Global IVD Infectious Diseases Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global IVD Infectious Diseases Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global IVD Infectious Diseases Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global IVD Infectious Diseases Product Life Cycle
3.3 Global IVD Infectious Diseases Sales by Manufacturers (2020-2025)
3.4 Global IVD Infectious Diseases Revenue Market Share by Manufacturers (2020-2025)
3.5 IVD Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global IVD Infectious Diseases Average Price by Manufacturers (2020-2025)
3.7 Manufacturers IVD Infectious Diseases Manufacturing Sites, Area Served, Product Type
3.8 IVD Infectious Diseases Market Competitive Situation and Trends
3.8.1 IVD Infectious Diseases Market Concentration Rate
3.8.2 Global 5 and 10 Largest IVD Infectious Diseases Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 IVD Infectious Diseases Industry Chain Analysis
4.1 IVD Infectious Diseases Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of IVD Infectious Diseases Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global IVD Infectious Diseases Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to IVD Infectious Diseases Market
5.7 ESG Ratings of Leading Companies
6 Global IVD Infectious Diseases Market by Region
6.1 Global IVD Infectious Diseases Market Size by Region
6.1.1 Global IVD Infectious Diseases Market Size by Region
6.1.2 Global IVD Infectious Diseases Market Size Market Share by Region
6.2 Global IVD Infectious Diseases Sales by Region
6.2.1 Global IVD Infectious Diseases Sales by Region
6.2.2 Global IVD Infectious Diseases Sales Market Share by Region
7 North America Market Overview
7.1 North America IVD Infectious Diseases Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America IVD Infectious Diseases Market Size by Type
7.3 North America IVD Infectious Diseases Market Size by Application
8 Europe Market Overview
8.1 Europe IVD Infectious Diseases Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe IVD Infectious Diseases Market Size by Type
8.3 Europe IVD Infectious Diseases Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific IVD Infectious Diseases Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific IVD Infectious Diseases Market Size by Type
9.3 Asia-Pacific IVD Infectious Diseases Market Size by Application
10 South America Market Overview
10.1 South America IVD Infectious Diseases Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America IVD Infectious Diseases Market Size by Type
10.3 South America IVD Infectious Diseases Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa IVD Infectious Diseases Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa IVD Infectious Diseases Market Size by Type
11.3 Middle East and Africa IVD Infectious Diseases Market Size by Application
12 IVD Infectious Diseases Market Production by Region
12.1 Global Production of IVD Infectious Diseases by Region(2020-2025)
12.2 Global IVD Infectious Diseases Revenue Market Share by Region (2020-2025)
12.3 Global IVD Infectious Diseases Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America IVD Infectious Diseases Production
12.4.1 North America IVD Infectious Diseases Production Growth Rate (2020-2025)
12.4.2 North America IVD Infectious Diseases Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe IVD Infectious Diseases Production
12.5.1 Europe IVD Infectious Diseases Production Growth Rate (2020-2025)
12.5.2 Europe IVD Infectious Diseases Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan IVD Infectious Diseases Production (2020-2025)
12.6.1 Japan IVD Infectious Diseases Production Growth Rate (2020-2025)
12.6.2 Japan IVD Infectious Diseases Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China IVD Infectious Diseases Production (2020-2025)
12.7.1 China IVD Infectious Diseases Production Growth Rate (2020-2025)
12.7.2 China IVD Infectious Diseases Production, Revenue, Price and Gross Margin (2020-2025)
13 IVD Infectious Diseases Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global IVD Infectious Diseases Sales Market Share by Type (2020-2033)
13.3 Global IVD Infectious Diseases Market Size Market Share by Type (2020-2033)
13.4 Global IVD Infectious Diseases Price by Type (2020-2033)
14 IVD Infectious Diseases Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global IVD Infectious Diseases Market Sales by Application (2020-2033)
14.3 Global IVD Infectious Diseases Market Size (M USD) by Application (2020-2033)
14.4 Global IVD Infectious Diseases Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 BD
15.1.1 BD Basic Information
15.1.2 BD IVD Infectious Diseases Product Overview
15.1.3 BD IVD Infectious Diseases Product Market Performance
15.1.4 BD Business Overview
15.1.5 BD SWOT Analysis
15.1.6 BD Recent Developments
15.2 BioMerieux
15.2.1 BioMerieux Basic Information
15.2.2 BioMerieux IVD Infectious Diseases Product Overview
15.2.3 BioMerieux IVD Infectious Diseases Product Market Performance
15.2.4 BioMerieux Business Overview
15.2.5 BioMerieux SWOT Analysis
15.2.6 BioMerieux Recent Developments
15.3 Abbott
15.3.1 Abbott Basic Information
15.3.2 Abbott IVD Infectious Diseases Product Overview
15.3.3 Abbott IVD Infectious Diseases Product Market Performance
15.3.4 Abbott Business Overview
15.3.5 Abbott SWOT Analysis
15.3.6 Abbott Recent Developments
15.4 Quidel
15.4.1 Quidel Basic Information
15.4.2 Quidel IVD Infectious Diseases Product Overview
15.4.3 Quidel IVD Infectious Diseases Product Market Performance
15.4.4 Quidel Business Overview
15.4.5 Quidel Recent Developments
15.5 Gen-Probe
15.5.1 Gen-Probe Basic Information
15.5.2 Gen-Probe IVD Infectious Diseases Product Overview
15.5.3 Gen-Probe IVD Infectious Diseases Product Market Performance
15.5.4 Gen-Probe Business Overview
15.5.5 Gen-Probe Recent Developments
15.6 Abbott
15.6.1 Abbott Basic Information
15.6.2 Abbott IVD Infectious Diseases Product Overview
15.6.3 Abbott IVD Infectious Diseases Product Market Performance
15.6.4 Abbott Business Overview
15.6.5 Abbott Recent Developments
15.7 Danaher
15.7.1 Danaher Basic Information
15.7.2 Danaher IVD Infectious Diseases Product Overview
15.7.3 Danaher IVD Infectious Diseases Product Market Performance
15.7.4 Danaher Business Overview
15.7.5 Danaher Recent Developments
15.8 Sysmex
15.8.1 Sysmex Basic Information
15.8.2 Sysmex IVD Infectious Diseases Product Overview
15.8.3 Sysmex IVD Infectious Diseases Product Market Performance
15.8.4 Sysmex Business Overview
15.8.5 Sysmex Recent Developments
15.9 Orasure
15.9.1 Orasure Basic Information
15.9.2 Orasure IVD Infectious Diseases Product Overview
15.9.3 Orasure IVD Infectious Diseases Product Market Performance
15.9.4 Orasure Business Overview
15.9.5 Orasure Recent Developments
15.10 Hologic
15.10.1 Hologic Basic Information
15.10.2 Hologic IVD Infectious Diseases Product Overview
15.10.3 Hologic IVD Infectious Diseases Product Market Performance
15.10.4 Hologic Business Overview
15.10.5 Hologic Recent Developments
15.11 Cepheid
15.11.1 Cepheid Basic Information
15.11.2 Cepheid IVD Infectious Diseases Product Overview
15.11.3 Cepheid IVD Infectious Diseases Product Market Performance
15.11.4 Cepheid Business Overview
15.11.5 Cepheid Recent Developments
15.12 Qiagen
15.12.1 Qiagen Basic Information
15.12.2 Qiagen IVD Infectious Diseases Product Overview
15.12.3 Qiagen IVD Infectious Diseases Product Market Performance
15.12.4 Qiagen Business Overview
15.12.5 Qiagen Recent Developments
15.13 Roche Diagnostics
15.13.1 Roche Diagnostics Basic Information
15.13.2 Roche Diagnostics IVD Infectious Diseases Product Overview
15.13.3 Roche Diagnostics IVD Infectious Diseases Product Market Performance
15.13.4 Roche Diagnostics Business Overview
15.13.5 Roche Diagnostics Recent Developments
15.14 Siemens Healthcare
15.14.1 Siemens Healthcare Basic Information
15.14.2 Siemens Healthcare IVD Infectious Diseases Product Overview
15.14.3 Siemens Healthcare IVD Infectious Diseases Product Market Performance
15.14.4 Siemens Healthcare Business Overview
15.14.5 Siemens Healthcare Recent Developments
15.15 Bio-Rad Laboratories
15.15.1 Bio-Rad Laboratories Basic Information
15.15.2 Bio-Rad Laboratories IVD Infectious Diseases Product Overview
15.15.3 Bio-Rad Laboratories IVD Infectious Diseases Product Market Performance
15.15.4 Bio-Rad Laboratories Business Overview
15.15.5 Bio-Rad Laboratories Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global IVD Infectious Diseases Market Size by Type (M USD)
Table 4. Global IVD Infectious Diseases Market Size by Application (M USD)
Table 5. IVD Infectious Diseases Market Size Comparison by Region (M USD)
Table 6. Global IVD Infectious Diseases Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global IVD Infectious Diseases Sales Market Share by Manufacturers (2020-2025)
Table 8. Global IVD Infectious Diseases Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global IVD Infectious Diseases Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Diseases as of 2024)
Table 11. Global Market IVD Infectious Diseases Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers IVD Infectious Diseases Manufacturing Sites and Area Served
Table 13. Manufacturers IVD Infectious Diseases Product Type
Table 14. Global IVD Infectious Diseases Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. IVD Infectious Diseases Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. IVD Infectious Diseases Market Size Comparison by Region (M USD)
Table 26. Global IVD Infectious Diseases Market Size by Region (2020-2033) & (M USD)
Table 27. Global IVD Infectious Diseases Market Size Market Share by Region (2020-2033)
Table 28. Global IVD Infectious Diseases Sales by Region (2020-2033) & (K Units)
Table 29. Global IVD Infectious Diseases Sales Market Share by Region (2020-2033)
Table 30. North America IVD Infectious Diseases Market Size by Country (2020-2033) & (M USD)
Table 31. North America IVD Infectious Diseases Sales by Country (2020-2033) & (K Units)
Table 32. North America IVD Infectious Diseases Sales by Type (K Units)
Table 33. North America IVD Infectious Diseases Market Size by Type (M USD)
Table 34. North America IVD Infectious Diseases Sales (K Units) by Type (2020-2033)
Table 35. North America IVD Infectious Diseases Market Size (M USD) by Type (2020-2033)
Table 36. North America IVD Infectious Diseases Sales by Application (K Units)
Table 37. North America IVD Infectious Diseases Market Size by Application (M USD)
Table 38. North America IVD Infectious Diseases Sales (K Units) by Application (2020-2033)
Table 39. North America IVD Infectious Diseases Market Size (M USD) by Application (2020-2033)
Table 40. Europe IVD Infectious Diseases Market Size by Country (2020-2033) & (M USD)
Table 41. Europe IVD Infectious Diseases Sales by Country (2020-2033) & (K Units)
Table 42. Europe IVD Infectious Diseases Sales by Type (K Units)
Table 43. Europe IVD Infectious Diseases Market Size by Type (M USD)
Table 44. Europe IVD Infectious Diseases Sales (K Units) by Type (2020-2033)
Table 45. Europe IVD Infectious Diseases Market Size (M USD) by Type (2020-2033)
Table 46. Europe IVD Infectious Diseases Sales by Application (K Units)
Table 47. Europe IVD Infectious Diseases Market Size by Application (M USD)
Table 48. Europe IVD Infectious Diseases Sales (K Units) by Application (2020-2033)
Table 49. Europe IVD Infectious Diseases Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific IVD Infectious Diseases Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific IVD Infectious Diseases Sales by Country (2020-2025) & (K Units)
Table 52. Asia-Pacific IVD Infectious Diseases Sales by Type (K Units)
Table 53. Asia-Pacific IVD Infectious Diseases Market Size by Type (M USD)
Table 54. Asia-Pacific IVD Infectious Diseases Sales (K Units) by Type (2020-2033)
Table 55. Asia-Pacific IVD Infectious Diseases Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific IVD Infectious Diseases Sales by Application (K Units)
Table 57. Asia-Pacific IVD Infectious Diseases Market Size by Application (M USD)
Table 58. Asia-Pacific IVD Infectious Diseases Sales (K Units) by Application (2020-2033)
Table 59. Asia-Pacific IVD Infectious Diseases Market Size (M USD) by Application (2020-2025)
Table 60. South America IVD Infectious Diseases Market Size by Country (2020-2033) & (M USD)
Table 61. South America IVD Infectious Diseases Sales by Country (2020-2033) & (K Units)
Table 62. South America IVD Infectious Diseases Sales by Type (K Units)
Table 63. South America IVD Infectious Diseases Market Size by Type (M USD)
Table 64. South America IVD Infectious Diseases Sales (K Units) by Type (2020-2033)
Table 65. South America IVD Infectious Diseases Market Size (M USD) by Type (2020-2033)
Table 66. South America IVD Infectious Diseases Sales by Application (K Units)
Table 67. South America IVD Infectious Diseases Market Size by Application (M USD)
Table 68. South America IVD Infectious Diseases Sales (K Units) by Application (2020-2033)
Table 69. South America IVD Infectious Diseases Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa IVD Infectious Diseases Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa IVD Infectious Diseases Sales by Country (2020-2033) & (K Units)
Table 72. Middle East and Africa IVD Infectious Diseases Sales by Type (K Units)
Table 73. Middle East and Africa IVD Infectious Diseases Market Size by Type (M USD)
Table 74. Middle East and Africa IVD Infectious Diseases Sales (K Units) by Type (2020-2033)
Table 75. Middle East and Africa IVD Infectious Diseases Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa IVD Infectious Diseases Sales by Application (K Units)
Table 77. Middle East and Africa IVD Infectious Diseases Market Size by Application (M USD)
Table 78. Middle East and Africa IVD Infectious Diseases Sales (K Units) by Application (2020-2033)
Table 79. Middle East and Africa IVD Infectious Diseases Market Size (M USD) by Application (2020-2033)
Table 80. Global IVD Infectious Diseases Production (K Units) by Region(2020-2025)
Table 81. Global IVD Infectious Diseases Revenue (US$ Million) by Region (2020-2025)
Table 82. Global IVD Infectious Diseases Revenue Market Share by Region (2020-2025)
Table 83. Global IVD Infectious Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. North America IVD Infectious Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Europe IVD Infectious Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Japan IVD Infectious Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. China IVD Infectious Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Global IVD Infectious Diseases Sales by Type (K Units)
Table 89. Global IVD Infectious Diseases Market Size by Type (M USD)
Table 90. Global IVD Infectious Diseases Sales (K Units) by Type (2020-2033)
Table 91. Global IVD Infectious Diseases Sales Market Share by Type (2020-2033)
Table 92. Global IVD Infectious Diseases Market Size (M USD) by Type (2020-2033)
Table 93. Global IVD Infectious Diseases Market Size Share by Type (2020-2033)
Table 94. Global IVD Infectious Diseases Sales (K Units) by Application
Table 95. Global IVD Infectious Diseases Market Size by Application(M USD)
Table 96. Global IVD Infectious Diseases Sales by Application (2020-2033) & (K Units)
Table 97. Global IVD Infectious Diseases Sales Market Share by Application (2020-2033)
Table 98. Global IVD Infectious Diseases Market Size by Application (2020-2033) & (M USD)
Table 99. Global IVD Infectious Diseases Market Share by Application (2020-2033)
Table 100. Global IVD Infectious Diseases Sales Growth Rate by Application (2020-2033)
Table 101. BD Basic Information
Table 102. BD IVD Infectious Diseases Product Overview
Table 103. BD IVD Infectious Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. BD Business Overview
Table 105. BD SWOT Analysis
Table 106. BD Recent Developments
Table 107. BioMerieux Basic Information
Table 108. BioMerieux IVD Infectious Diseases Product Overview
Table 109. BioMerieux IVD Infectious Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. BioMerieux Business Overview
Table 111. BioMerieux SWOT Analysis
Table 112. BioMerieux Recent Developments
Table 113. Abbott Basic Information
Table 114. Abbott IVD Infectious Diseases Product Overview
Table 115. Abbott IVD Infectious Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Abbott Business Overview
Table 117. Abbott SWOT Analysis
Table 118. Abbott Recent Developments
Table 119. Quidel Basic Information
Table 120. Quidel IVD Infectious Diseases Product Overview
Table 121. Quidel IVD Infectious Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Quidel Business Overview
Table 123. Quidel Recent Developments
Table 124. Gen-Probe Basic Information
Table 125. Gen-Probe IVD Infectious Diseases Product Overview
Table 126. Gen-Probe IVD Infectious Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Gen-Probe Business Overview
Table 128. Gen-Probe Recent Developments
Table 129. Abbott Basic Information
Table 130. Abbott IVD Infectious Diseases Product Overview
Table 131. Abbott IVD Infectious Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Abbott Business Overview
Table 133. Abbott Recent Developments
Table 134. Danaher Basic Information
Table 135. Danaher IVD Infectious Diseases Product Overview
Table 136. Danaher IVD Infectious Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Danaher Business Overview
Table 138. Danaher Recent Developments
Table 139. Sysmex Basic Information
Table 140. Sysmex IVD Infectious Diseases Product Overview
Table 141. Sysmex IVD Infectious Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Sysmex Business Overview
Table 143. Sysmex Recent Developments
Table 144. Orasure Basic Information
Table 145. Orasure IVD Infectious Diseases Product Overview
Table 146. Orasure IVD Infectious Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Orasure Business Overview
Table 148. Orasure Recent Developments
Table 149. Hologic Basic Information
Table 150. Hologic IVD Infectious Diseases Product Overview
Table 151. Hologic IVD Infectious Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Hologic Business Overview
Table 153. Hologic Recent Developments
Table 154. Cepheid Basic Information
Table 155. Cepheid IVD Infectious Diseases Product Overview
Table 156. Cepheid IVD Infectious Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. Cepheid Business Overview
Table 158. Cepheid Recent Developments
Table 159. Qiagen Basic Information
Table 160. Qiagen IVD Infectious Diseases Product Overview
Table 161. Qiagen IVD Infectious Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. Qiagen Business Overview
Table 163. Qiagen Recent Developments
Table 164. Roche Diagnostics Basic Information
Table 165. Roche Diagnostics IVD Infectious Diseases Product Overview
Table 166. Roche Diagnostics IVD Infectious Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 167. Roche Diagnostics Business Overview
Table 168. Roche Diagnostics Recent Developments
Table 169. Siemens Healthcare Basic Information
Table 170. Siemens Healthcare IVD Infectious Diseases Product Overview
Table 171. Siemens Healthcare IVD Infectious Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 172. Siemens Healthcare Business Overview
Table 173. Siemens Healthcare Recent Developments
Table 174. Bio-Rad Laboratories Basic Information
Table 175. Bio-Rad Laboratories IVD Infectious Diseases Product Overview
Table 176. Bio-Rad Laboratories IVD Infectious Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 177. Bio-Rad Laboratories Business Overview
Table 178. Bio-Rad Laboratories Recent Developments
List of Figures
Figure 1. Product Picture of IVD Infectious Diseases
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global IVD Infectious Diseases Market Size (M USD), 2024-2033
Figure 5. Global IVD Infectious Diseases Market Size (M USD) (2020-2033)
Figure 6. Global IVD Infectious Diseases Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. IVD Infectious Diseases Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global IVD Infectious Diseases Product Life Cycle
Figure 13. IVD Infectious Diseases Sales Share by Manufacturers in 2024
Figure 14. Global IVD Infectious Diseases Revenue Share by Manufacturers in 2024
Figure 15. IVD Infectious Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market IVD Infectious Diseases Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by IVD Infectious Diseases Revenue in 2024
Figure 18. Industry Chain Map of IVD Infectious Diseases
Figure 19. Global IVD Infectious Diseases Market PEST Analysis
Figure 20. Global IVD Infectious Diseases Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global IVD Infectious Diseases Market Size by Region
Figure 27. Global IVD Infectious Diseases Market Size Market Share by Region (2020-2033)
Figure 28. Global IVD Infectious Diseases Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America IVD Infectious Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 31. North America IVD Infectious Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America IVD Infectious Diseases Market Size (M USD) by Country
Figure 33. USA IVD Infectious Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 34. USA IVD Infectious Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada IVD Infectious Diseases Sales (K Units) and Growth Rate (2020-2033)
Figure 36. Canada IVD Infectious Diseases Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico IVD Infectious Diseases Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico IVD Infectious Diseases Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America IVD Infectious Diseases Market Size (M USD)by Type
Figure 40. North America IVD Infectious Diseases Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe IVD Infectious Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 43. Europe IVD Infectious Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe IVD Infectious Diseases Market Size (M USD) by Country
Figure 45. Germany IVD Infectious Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. Germany IVD Infectious Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France IVD Infectious Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. France IVD Infectious Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. IVD Infectious Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. U.K. IVD Infectious Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy IVD Infectious Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Italy IVD Infectious Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain IVD Infectious Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 54. Spain IVD Infectious Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe IVD Infectious Diseases Market Size (M USD) by Type
Figure 56. Europe IVD Infectious Diseases Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific IVD Infectious Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 59. Asia-Pacific IVD Infectious Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific IVD Infectious Diseases Market Size (M USD) by Country
Figure 61. China IVD Infectious Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. China IVD Infectious Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan IVD Infectious Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Japan IVD Infectious Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea IVD Infectious Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. South Korea IVD Infectious Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India IVD Infectious Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. India IVD Infectious Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia IVD Infectious Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 70. Southeast Asia IVD Infectious Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific IVD Infectious Diseases Market Size (M USD) by Type
Figure 72. Asia-Pacific IVD Infectious Diseases Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America IVD Infectious Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 75. South America IVD Infectious Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America IVD Infectious Diseases Market Size (M USD) by Country
Figure 77. Brazil IVD Infectious Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Brazil IVD Infectious Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina IVD Infectious Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Argentina IVD Infectious Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia IVD Infectious Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 82. Columbia IVD Infectious Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America IVD Infectious Diseases Market Size (M USD) by Type
Figure 84. South America IVD Infectious Diseases Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa IVD Infectious Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 87. Middle East and Africa IVD Infectious Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa IVD Infectious Diseases Market Size (M USD) by Country
Figure 89. Saudi Arabia IVD Infectious Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. Saudi Arabia IVD Infectious Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE IVD Infectious Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. UAE IVD Infectious Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt IVD Infectious Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Egypt IVD Infectious Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria IVD Infectious Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. Nigeria IVD Infectious Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa IVD Infectious Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 98. South Africa IVD Infectious Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa IVD Infectious Diseases Market Size (M USD) by Type
Figure 100. Middle East and Africa IVD Infectious Diseases Market Size (M USD) by Application
Figure 101. Global IVD Infectious Diseases Production Market Share by Region (2020-2025)
Figure 102. North America IVD Infectious Diseases Production (K Units) Growth Rate (2020-2025)
Figure 103. Europe IVD Infectious Diseases Production (K Units) Growth Rate (2020-2025)
Figure 104. Japan IVD Infectious Diseases Production (K Units) Growth Rate (2020-2025)
Figure 105. China IVD Infectious Diseases Production (K Units) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global IVD Infectious Diseases Market Size by Type (M USD)
Figure 108. Sales Market Share of IVD Infectious Diseases by Type (2020-2033)
Figure 109. Sales Market Share of IVD Infectious Diseases by Type in 2024
Figure 110. Market Size Share of IVD Infectious Diseases by Type (2020-2033)
Figure 111. Market Size Share of IVD Infectious Diseases by Type in 2024
Figure 112. Global IVD Infectious Diseases Price (USD/Unit) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global IVD Infectious Diseases Market Size by Application(M USD)
Figure 115. Global IVD Infectious Diseases Market Share by Application
Figure 116. Global IVD Infectious Diseases Sales Market Share by Application (2020-2033)
Figure 117. Global IVD Infectious Diseases Sales Market Share by Application in 2024
Figure 118. Global IVD Infectious Diseases Market Share by Application (2020-2033)
Figure 119. Global IVD Infectious Diseases Market Share by Application in 2024
Figure 120. Global IVD Infectious Diseases Sales Growth Rate by Application (2020-2033)